Navigation Links
Newly Identified Strains Of Chlamydia Trachomatis – A Gateway To New Disease

Chlamydia trachomatis, a bacterium, which is one of the leading cause for sexually transmitted diseases and the second leading cause for blindness globally, is said to be// evolving at a rate faster than scientists would have imagined. The scientists from Children’s Hospital Oakland Research Institute (CHORI) were the first to conclude this with the help of a new study.

The Scientists believe that the bacterium is evolving through a process called recombination where genes from one or more strains combine to create new strains and – theoretically – new diseases.

The study is featured in the November issue of Genome Research and was led by Dr. Deborah Dean MD, MPH, senior scientist at Children's Hospital Oakland Research Institute (CHORI). Her research suggests that since Chlamydia trachomatis evolves through recombination where one or more strains combine, the traditional method of studying a single gene to track the transmission of the bacterium is wrong.

'What we found is an organism that not only evolves rapidly, but in ways that we thought were rare. We also discovered that this organism can customize its attack,' said Dr. Dean. 'Consequently, the constant flux of the bacterium could serve as a gateway for new emerging diseases, but more research needs to be conducted to understand if and how this is happening.'

600 million people are infected across the globe with Chlamydia trachomatis and 8 million are already blind or severely visually impaired. In some parts of third-world countries, more than 90% of the population is infected. Chlamydia trachomatis has a variety of strains; different strains are responsible for different diseases. Some strains cause sexually transmitted diseases while others cause eye infections.

Blinding trachoma is caused by repeated eye infections that cause scarring, which result in the eyelashes turning in-wards. Bacterial infection develops as the eyelashes scratch the surface of
'"/>




Page: 1 2

Related medicine news :

1. Obesity The Major Cause Of The Increase In Newly Diagnosed Diabetes
2. Newly Cloned Wheat Gene May Boosts Foods Nutrient Contents – Says A Researc
3. Newly Discovered Immune Defense May Be Impaired In CF Airways
4. Differences Between BP Medicines and Newly-Diagnosed Diabetes Identified
5. A Newly Identified Immunosuppressive Protein in Rheumatoid Arthritis
6. Moratorium Proposed on Advertisements of Newly Approved Drugs
7. Potential New Cancer Gene Identified
8. Alcohol Dependence Gene Identified
9. More Causes of Bladder Cancer Identified
10. Dyslexia Gene Identified and Called "KIAA0319"
11. New Enzyme Identified For Arthritis

Post Your Comments:
(Date:12/2/2009)...ewswire-USNewswire/ -- Pro-abortion activists will...r campaign against the U.S. House bill,s pro-life ...r Life President and CEO Charmaine Yoest released ... effort to expand taxpayer funding of abortion: ,...eminist groups and the abortion lobby actually dem...
(Date:12/2/2009)...ton Post Highlights Dangers ,, WASHINGTON, ...ic bishops have their way, many medical treatments... be under threat. The pressure that the US bishop...re reform has been widely reported. An ad in this ...pact if that pressure to influence healthcare poli...
(Date:12/2/2009)...e/ -- The Universities of Sassari and Cagliari (...ctors from the United States, announced today the ...ng that Pecorino cheese contains high amounts of C...turated fatty acid naturally found in certain food...humans. ,, The study, conducted in Sardinia, ...
(Date:12/2/2009)... -- Proving true the old adage that "The sum is gr...st Hospital Southlake (THHMHS) is partnering with ...am to make the holiday season a little brighter fo...ning their efforts to collect unwrapped toys and c...ulminating in a final event on Tuesday, December ...
(Date:12/2/2009)..., but risk is unclear , , WEDNESDAY, Dec...dence that the average cigarette is crawling with ...isease. , But as one spokesman for a tobacco co...en,t sure what, if any, hazard the germs pose. And...round us every day of our lives. , Still, the ...
Breaking Medicine News(10 mins):Health News:Everybody's Healthcare Is Threatened by Catholic Bishops' Interference 2Health News:New Study Confirms Health Benefits of Pecorino Romano Cheese 2Health News:New Study Confirms Health Benefits of Pecorino Romano Cheese 3Health News:Texas Health Harris Methodist Hospital Southlake Joins With U.S. Marine Corps Reserves Toys for Tots to Spread Holiday Cheer 2Health News:Smokers Inhaling Germs With Each Cigarette 2
...nnounced Plans to Separate Medical T...ILLE, Ind., Feb. 29 Hillenbrand,Industries, Inc. ...it has,commenced a cash tender offer to purchase a...nding as of February 29,2008, pursuant to an Offer...
...sponse in the adult brain , , FRIDAY, Feb....d to go ga-ga when they see a baby? , Scientists ...ng a baby,s face lit up a specific region of the a...neural basis for protective, nurturing feelings tr...
...as a book in the biological sciences proved as pre...ng the Origin of Malignant Tumours . Out of print ...ack down, the book is now available as a new and a...mours had a huge impact on cancer research. In it...
...Minnesota facing a $935 million budget deficit, ma... to ensure that the health and independence of,the...ed., "On the one hand, legislators are discussing...s to needed services,for people with disabilities,...
... receiving heart, liver and lung transplants at UC...istically significant levels, according to new dat...t Recipients (SRTR). , Released on January 11, ..., post-transplant survival rates, and organ recove...
...Inc.,s (NYSE: SNN ; LSE: SN) Orthopaedic Reconstr...pointment of Todd Durniak as the senior vice,presi...and Australia.,Durniak will focus on further devel...s appointment rounds out the Unit,s Global Managem...
Other Medicine News:Health News:Hillenbrand Industries, Inc. Announces 'Any and All' Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009 2Health News:Hillenbrand Industries, Inc. Announces 'Any and All' Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009 3Health News:Hillenbrand Industries, Inc. Announces 'Any and All' Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009 4Health News:Hillenbrand Industries, Inc. Announces 'Any and All' Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009 5Health News:Babies Really Can Light Up Your Life 2Health News:Babies Really Can Light Up Your Life 3Health News:Survival rates exceed national averages for UCSF heart, liver and lung transplant programs 2Health News:Smith & Nephew Orthopaedic Reconstruction Global Management Team Announced 2Health News:Smith & Nephew Orthopaedic Reconstruction Global Management Team Announced 3Health News:Smith & Nephew Orthopaedic Reconstruction Global Management Team Announced 4
(Date:12/2/2009)...IEJO, Calif., Dec. 2 Cla... and services resource for pathologists, oncologis...d a Chief Financial Officer transition plan that c...driguez to become its Senior Vice President and Ch... J. Land, age 64, the current Senior Vice Presiden...
(Date:12/1/2009)... Calif., Dec. 1 Patient ...X) announced today that it has appointed Marc L. R...fficer, Treasurer and Corporate Secretary, replaci.... Prior to joining Patient Safety Technologies, I...nancial Officer, Treasurer and Corporate Secretary...
(Date:12/1/2009)...N, N.J., Dec. 1 Johnson & John....C. announced today that it has submitted a New Dr...inistration (FDA) for tapentadol extended release ...r the management of moderate to severe chronic pai...onic pain, defined as pain that persists for long ...
Breaking Medicine Technology:Clarient Announces CFO Transition Plan 2Clarient Announces CFO Transition Plan 3Clarient Announces CFO Transition Plan 4Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer 2New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 2New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 3New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 4New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 5New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 6New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 7AMA Reaction to President Obamas Address on Health System Reform 56698 1AMA Reaction to President Obamas Address on Health System Reform 56698 2Yeast unravels effects of chemotherapy drugs 56697 1Vanderbilt Experts For Health Care Debate 56693 1Vanderbilt Experts For Health Care Debate 56693 2
...The Miami Jewish Home and Hospital,Berma Research ...oday,announced that they are actively enrolling pa... trial that is evaluating the safety and efficacy,... for mild-to-moderate,Alzheimer,s disease., Accor...tion, more than,5 million people in the United Sta...
...lysis from ATHENA Study showed that Multaq(R) on t... total number of hospital days,by 28% in patients ... Nov. 11 New data from the,landmark ATHENA trial ...incidence and total duration of hospital stays amo...r (AF/AFL). This post-hoc analysis was presented,a...
Other Medicine Technology:Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 2Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 3Dronedarone (Multaq(R)) Reduced the Incidence and Duration of Hospitalization in Patients with Atrial Fibrillation 2Dronedarone (Multaq(R)) Reduced the Incidence and Duration of Hospitalization in Patients with Atrial Fibrillation 3Dronedarone (Multaq(R)) Reduced the Incidence and Duration of Hospitalization in Patients with Atrial Fibrillation 4Dronedarone (Multaq(R)) Reduced the Incidence and Duration of Hospitalization in Patients with Atrial Fibrillation 5Dronedarone (Multaq(R)) Reduced the Incidence and Duration of Hospitalization in Patients with Atrial Fibrillation 6
Philips Follower Catheters
Finlayson Ureteral Access Set
Cook Enforcer Balloon Dilation Catheters
Ascend™ Ureteral Dilation Balloon Catheter
Medicine Products: